$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
Jaguar Land Rover cuts 500 UK roles after sales slide
11:20am, Thursday, 17'th Jul 2025
Jaguar Land Rover is cutting up to 500 management jobs in the UK following a sharp drop in global sales and trade disruption with the US. The voluntary redundancy programme affects around 1.5% of the
Abbott Laboratories shares slide as cautious guidance overshadows Q2 revenue beat
10:32am, Thursday, 17'th Jul 2025
Abbott Laboratories (NYSE:ABT) shares moved more than 6% lower as disappointing guidance overshadowed solid second quarter results. The company now expects full-year earnings per share (EPS) in the
Abbott (ABT) Reports Q2 Earnings: What Key Metrics Have to Say
10:31am, Thursday, 17'th Jul 2025
Although the revenue and EPS for Abbott (ABT) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street est
Abbott (ABT) Q2 Earnings and Revenues Top Estimates
09:41am, Thursday, 17'th Jul 2025
Abbott (ABT) came out with quarterly earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.14 per share a year ago.
Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
08:39am, Thursday, 17'th Jul 2025
U.S. stock futures were mostly lower this morning, with the Dow futures falling around 0.2% on Thursday.
Dow Jones down and Nasdaq flat as Abbott outlook disappoints, Pepsi impresses
08:16am, Thursday, 17'th Jul 2025
US stocks are anticipated to be slow out of the blocks on Thursday as earnings emerged from PepsiCo and Abbott Laboratories, with retail sales and manufacturing surveys due. Dow Jones futures were dow
Abbott Labs Stock Dives After Earnings Miss. Why Rising Sales Fail to Lift Shares.
08:16am, Thursday, 17'th Jul 2025
Abbott Laboratories stock falls even as the company reports second-quarter sales that top expectations.
Abbott beats quarterly profit estimates on medical devices demand
07:34am, Thursday, 17'th Jul 2025
Abbott beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its medical devices including continuous glucose monitors.
Abbott Reports Second-Quarter 2025 Results
07:30am, Thursday, 17'th Jul 2025
Second-quarter reported sales growth of 7.4 percent; organic sales growth of 6.9 percent or 7.5 percent excluding COVID-19 testing-related sales1 Second-quarter GAAP diluted EPS of $1.01; adjusted dil
Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
11:43am, Wednesday, 16'th Jul 2025
Abbott Laboratories ABT will release earnings results for the second quarter, before the opening bell on Thursday, July 17.
3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS
05:56pm, Tuesday, 15'th Jul 2025
The broader market's historic rebound may make it necessary to consider some defensive positions in the portfolio, and these medical stocks fit the bill ahead of their Q2 reports.
Sell ABT Stock Ahead Of Its Q2 Earnings?
07:35am, Tuesday, 15'th Jul 2025
Abbott Laboratories (NYSE:ABT) is scheduled to announce its second-quarter earnings on Thursday, July 17, 2025. For traders who focus on events, examining the historical reactions of the stock to earn
Countdown to Abbott (ABT) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
10:16am, Monday, 14'th Jul 2025
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Abbott (ABT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quart
ABT to Report Q2 Earnings: CGM and Cardiac Devices in Focus
09:31am, Monday, 14'th Jul 2025
Abbott eyes Q2 growth with strong CGM momentum, cardiac device wins and resilient performance across key segments.
3 Dividend Growth Stocks to Buy and Hold
06:40am, Saturday, 12'th Jul 2025
What's better than a great dividend? A great dividend that's growing.
Sign In
Buy ABT